Coming Full Circle, Identification, & Therapeutic Targeting of Extrachromosomal DNA
Time: 11:45 am
day: Pre-Conference Biomarker Focus Day AM
Details:
- Discovery and utilization of CHK1 and RNR inhibitors for the treatment of oncogene amplified cancers
- Establishment of a diagnostic for identification of patients with amp/ecDNA containing tumors
- Addressing the clinical unmet need presented by oncogene amplified tumors utilizing ecDTx therapies
